Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer The multisite blinded analysis across a cohort of 188 immune checkpoint inhibitor-treated patients demonstrated the ...
Comparisons of survival outcomes of antibody-drug-conjugates in metastatic breast cancer: A network meta-analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback